Recro Pharma, Inc. announced on January 18, 2022, Gerri A. Henwood, a Class II member of the Board of Directors notified the Company of her intent to resign from the Board, effective January 18, 2022. After working with the Company for the last 12 months on transition, Ms. Henwood is resigning to focus on her role as Chief Executive Officer and director of Baudax Bio, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | +0.92% | -.--% | +213.84% |
Apr. 08 | Societal CDMO, Inc. Announces Board and Committee Resignations | CI |
Apr. 08 | Societal CDMO, Inc.(NasdaqCM:SCTL) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
+213.84% | 116M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- SCTL Stock
- News Societal CDMO, Inc.
- Recro Pharma, Inc. Announces Resignation of Gerri A. Henwood from Board of Directors